• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PORT; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PORT; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Patient Problems Erythema (1840); Unspecified Infection (1930); Implant Pain (4561); Swelling/ Edema (4577)
Event Date 12/13/2019
Event Type  Injury  
Event Description
Hospitalization prolonged.Adverse event(s) attributed to: gr.3 infections and infestations, catheter-related "inf." pt status post c1 consolidation (c1d1 on "12/02"), who presents with complaints of pain, tenderness, and edema to her right upper chest port.She had a clinic visit on (b)(6) 2019 where she received a platelet transfusion, and she had no port issues at the time.Exam on admission notable for pain / tenderness, mild edema, slight erythema, no drainage to her right upper chest port site.Chest x-ray negative.Blood culture x2 pending.Started on iv vancomycin empirically on admission.Port site improved in appearance and tenderness.Patient continued on iv vancomycin while cultures were pending.Blood culture x no growth to date on (b)(6) 2019 with stable counts; patient has remained afebrile and port site continues to look stable without erythema or edema.Patient is stable and ready for discharge home; she will complete 7 dy course of doxycycline to cover mrsa infection as well as home prophylactic antibiotics.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PORT
Type of Device
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
MDR Report Key17932261
MDR Text Key325741244
Report NumberMW5146939
Device Sequence Number1
Product Code LJT
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Unknown
Type of Report Initial
Report Date 10/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/12/2023
Patient Sequence Number1
Treatment
CYTARABINE 10000 MG
Patient Age61 YR
Patient SexFemale
Patient Weight53 KG
-
-